ModelEdge
Regeneron Pharmaceuticals, Inc.
REGN
Filing type
10-K
Filing date
Feb 4, 2025
Updated
Feb 5, 2025 ยท 7:18 AM

Filing

10-KFY 2023

Exhibits

EX-4.1DESCRIPTION OF SECURITIESEX-10.8 1AMENDMENT AGREEMENT, DATED DECEMBER 30, 2014 BETWEEN BAYER AND REGISTRANTEX-19.1INSIDER TRADING POLICYEX-21.1SUBSIDIARIES OF THE REGISTRANTEX-23.1CONSENT OF PRICEWATERHOUSECOOPERS LLPEX-31.1CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)EX-31.2CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)EX-32CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350GRAPHICGRAPHIC